Medicare Enrolled

Dr. Shivang Joshi, MD

Neurology · Westborough, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
33 LYMAN ST STE 400, Westborough, MA 01581
5088980055
In practice since 2009 (17 years)
NPI: 1902034531 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Joshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Joshi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Joshi

Dr. Shivang Joshi is a neurology specialist in Westborough, MA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Joshi performed 11,974 Medicare services across 273 unique beneficiaries.

Between the years covered by Open Payments, Dr. Joshi received a total of $1,124,413 from 60 pharmaceutical and/or device companies across 2325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Joshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 5% volume in MA $1,124,413 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,974
Medicare services
Top 5% in MA for neurology
273
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~704 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
11,400 $5 $13
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
146 $44 $375
Injection of anesthetic agent and/or steroid into other nerve or branch 145 $69 $210
Facial nerve injection with anesthetic and/or steroid
An injection of an anesthetic agent and/or steroid into the facial nerve. This procedure delivers medication directly to the nerve.
84 $130 $485
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
57 $126 $434
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
48 $100 $396
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
42 $142 $548
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $113 $500
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $64 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,124,413
Total received (2018-2024)
Avg $160,630/year across 7 years
Top 1% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
2,325
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$946,499 (84.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$154,101 (13.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,814 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$96,955
2023
$87,221
2022
$177,116
2021
$250,203
2020
$195,504
2019
$191,789
2018
$125,626

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$59,437
Lundbeck LLC
$16,223
Axsome Therapeutics, Inc.
$10,473
SCILEX PHARMACEUTICALS INC.
$7,872
Eli Lilly and Company
$1,750
Tonix Medicines, Inc.
$520
PFIZER INC.
$248
Lilly USA, LLC
$218
Eisai Inc.
$97
Teva Pharmaceuticals USA, Inc.
$76
Otsuka America Pharmaceutical, Inc.
$42
Top 3 companies account for 88.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$303,172
Amgen Inc.
$137,143
ABBVIE INC.
$118,497
Biohaven Pharmaceuticals, Inc.
$117,781
Biohaven Pharmaceutical Holding Company Ltd.
$73,876
Teva Pharmaceuticals USA, Inc.
$56,484
Eli Lilly and Company
$56,261
AbbVie Inc.
$43,961
IMPEL PHARMACEUTICALS INC.
$41,042
Allergan, Inc.
$32,392
Supernus Pharmaceuticals, Inc.
$28,805
Lundbeck LLC
$28,332
Allergan Inc.
$12,666
Assertio Therapeutics, Inc.
$12,344
Currax Pharmaceuticals LLC
$10,852
Axsome Therapeutics, Inc.
$10,473
SCILEX PHARMACEUTICALS INC.
$7,903
Promius Pharma LLC
$7,738
BioDelivery Sciences International, Inc.
$7,254
H. Lundbeck A S
$4,664
Upsher-Smith Laboratories LLC
$2,420
Novartis Pharmaceuticals Corporation
$2,400
Amneal Pharmaceuticals LLC
$1,872
PFIZER INC.
$1,602
UPSHER-SMITH LABORATORIES LLC
$790
NOVARTIS PHARMACEUTICALS CORPORATION
$746
Tonix Medicines, Inc.
$520
Avanir Pharmaceuticals, Inc.
$345
GENZYME CORPORATION
$281
Pernix Therapeutics Holdings, Inc.
$214
ACADIA Pharmaceuticals Inc
$171
ASSERTIO THERAPEUTICS, Inc.
$167
Eisai Inc.
$144
Acorda Therapeutics, Inc
$118
Novocure Inc.
$101
ARBOR PHARMACEUTICALS, INC.
$94
Dr.Reddy's Laboratories,Inc.
$92
Sunovion Pharmaceuticals Inc.
$86
UCB, Inc.
$74
Alexion Pharmaceuticals, Inc.
$51
LivaNova USA, Inc.
$49
Harmony Biosciences LLC
$49
RedHill Biopharma Inc.
$48
Endo Pharmaceuticals Inc.
$47
Otsuka America Pharmaceutical, Inc.
$42
TerSera Therapeutics LLC
$38
Adamas Pharmaceuticals, Inc.
$36
Neurocrine Biosciences, Inc.
$28
Ipsen Biopharmaceuticals, Inc
$17
Mallinckrodt LLC
$16
Zyla Life Sciences
$16
Greenwich Biosciences, Inc.
$16
Shire North American Group Inc
$15
Neurelis, Inc.
$13
Egalet US Inc
$13
PTC Therapeutics, Inc.
$12
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Abbott Laboratories
$12
Zyla Life Sciences, Inc.
$6
GE HEALTHCARE
$3
Top 3 companies account for 49.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BELBUCA · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · Briviact · CAMBIA · COMIRNATY · CONTRAVE · Cambia · DYSPORT · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMFLAZA · EMGALITY · ERGOMAR · Epidiolex · Fycompa · GOCOVRI · Gralise · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KISUNLA · LEMTRADA · LYRICA · Leqembi · Movantik · NASCOBAL · NUEDEXTA · NUPLAZID · NURTEC ODT · ONFI · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Oncology · Optune · PAXLOVID · PRIALT · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RELISTOR · REXULTI · REYVOW · RYTARY · SILENOR · SOLIRIS · SPRIX · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREXIMET · TROKENDI XR · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · VALTOCO · VNS - Sentiva · VRAYLAR · VYEPTI · VYVANSE · Wakix · ZEMBRACE SYMTOUCH · ZIPSOR · ZOMIG · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in MA.

Looking for a neurology specialist in Westborough?
Compare neurologists in the Westborough area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
130
Per 100K population
15.1
County median income
$93,561
Nearest hospital
WESTBOROUGH BEHAVIORAL HEALTHCARE HOSPITAL LLC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Joshi is a mixed practice specialist, with above-average Medicare volume (top 5% in MA), with speaking/promotional industry engagement in the top 1% of MA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Joshi experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Joshi performed 11,400 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Joshi receive payments from pharmaceutical companies?
Yes. Dr. Joshi received a total of $1,124,413 from 60 companies across 2,325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Joshi's costs compare to other neurologists in Westborough?
Dr. Joshi's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Joshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →